Comparison of Ahlstrom Grade 226, Munktell TFN, and Whatman 903 Filter Papers for Dried Blood Spot Specimen Collection and Subsequent HIV-1 Load and Drug Resistance Genotyping Analysis

ABSTRACT Dried blood spots (DBS) collected onto filter paper have eased the difficulty of blood collection in resource-limited settings. Currently, Whatman 903 (W-903) filter paper is the only filter paper that has been used for HIV load and HIV drug resistance (HIVDR) testing. We therefore evaluated two additional commercially available filter papers, Ahlstrom grade 226 (A-226) and Munktell TFN (M-TFN), for viral load (VL) testing and HIVDR genotyping using W-903 filter paper as a comparison group. DBS specimens were generated from 344 adult patients on antiretroviral therapy (ART) in Botswana. The VL was measured with NucliSENS EasyQ HIV-1 v2.0, and genotyping was performed for those specimens with a detectable VL (≥2.90 log10 copies/ml) using an in-house method. Bland-Altman analysis revealed a strong concordance in quantitative VL analysis between W-903 and A-226 (bias = −0.034 ± 0.246 log10 copies/ml [mean difference ± standard deviation]) and W-903 and M-TFN (bias = −0.028 ± 0.186 log10 copies/ml) filter papers, while qualitative VL analysis for virological failure determination, defined as a VL of ≥3.00 log10 copies/ml, showed low sensitivities for A-266 (71.54%) and M-TFN (65.71%) filter papers compared to W-903 filter paper. DBS collected on M-TFN filter paper had the highest genotyping efficiency (100%) compared to W-903 and A-226 filter papers (91.7%) and appeared more sensitive in detecting major HIVDR mutations. DBS collected on A-226 and M-TFN filter papers performed similarly to DBS collected on W-903 filter paper for quantitative VL analysis and HIVDR detection. Together, the encouraging genotyping results and the variability observed in determining virological failure from this small pilot study warrant further investigation of A-226 and M-TFN filter papers as specimen collection devices for HIVDR monitoring surveys.

[1]  Erin K. Rottinghaus,et al.  Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving first-line antiretroviral therapy. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  Tommy F. Liu,et al.  Automating HIV Drug Resistance Genotyping with RECall, a Freely Accessible Sequence Analysis Tool , 2012, Journal of Clinical Microbiology.

[3]  Erin K. Rottinghaus,et al.  Optimization of a Low Cost and Broadly Sensitive Genotyping Assay for HIV-1 Drug Resistance Surveillance and Monitoring in Resource-Limited Settings , 2011, PloS one.

[4]  C. Charpentier,et al.  Usefulness of a genotypic resistance test using dried blood spot specimens in African HIV-infected children with virological failure according to the 2010-revised WHO criteria , 2011, Archives of Virology.

[5]  M. Peeters,et al.  Effect of storage conditions of dried plasma and blood spots on HIV-1 RNA quantification and PCR amplification for drug resistance genotyping. , 2010, The Journal of antimicrobial chemotherapy.

[6]  J. Nkengasong,et al.  Development and Application of a Broadly Sensitive Dried-Blood-Spot-Based Genotyping Assay for Global Surveillance of HIV-1 Drug Resistance , 2010, Journal of Clinical Microbiology.

[7]  Hilda A. Valdez-Salazar,et al.  Genotypic testing for HIV-1 drug resistance using dried blood samples , 2010, Archives of Virology.

[8]  Tom Oosterlaken,et al.  Measuring human immunodeficiency virus type 1 RNA loads in dried blood spot specimens using NucliSENS EasyQ HIV-1 v2.0. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[9]  L. Sandvik,et al.  Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  T. F. Rinke de Wit,et al.  Dried Fluid Spots for HIV Type-1 Viral Load and Resistance Genotyping: A Systematic Review , 2009, Antiviral therapy.

[11]  D. Pillay,et al.  Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance. , 2008, The Journal of antimicrobial chemotherapy.

[12]  M. Parker,et al.  Evaluation of dried blood spot specimens for HIV-1 drug-resistance testing using the Trugene HIV-1 genotyping assay. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[13]  C. de Mendoza,et al.  HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4°C , 2008, The Journal of antimicrobial chemotherapy.

[14]  F. Antunes,et al.  Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola. , 2008, The Journal of antimicrobial chemotherapy.

[15]  D. Bennett,et al.  World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites , 2008, Antiviral therapy.

[16]  D. Bennett,et al.  The World Health Organization's global strategy for prevention and assessment of HIV drug resistance , 2008, Antiviral therapy.

[17]  D. Bennett,et al.  Darunavir: pharmacokinetics and drug interactions. , 2008 .

[18]  W. Heneine,et al.  High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients , 2007, AIDS.

[19]  S. Luchters,et al.  Feasibility of Detecting Human Immunodeficiency Virus Type 1 Drug Resistance in DNA Extracted from Whole Blood or Dried Blood Spots , 2007, Journal of Clinical Microbiology.

[20]  Paul Sandstrom,et al.  HIV-1 drug resistance surveillance using dried whole blood spots , 2007, Antiviral therapy.

[21]  W. Heneine,et al.  Evaluation of Dried Blood Spots for Human Immunodeficiency Virus Type 1 Drug Resistance Testing , 2006, Journal of Clinical Microbiology.

[22]  S. Ray,et al.  A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts. , 2006, Journal of virological methods.

[23]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[24]  W. Grove Statistical Methods for Rates and Proportions, 2nd ed , 1981 .

[25]  H. Toutenburg Fleiss, J. L.: Statistical Methods for Rates and Proportions. John Wiley & Sons, New York‐London‐Sydney‐Toronto 1973. XIII, 233 S. , 1974 .

[26]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .